… This is the first randomized, placebo-controlled trial using MA … use at the time of first-line
cytotoxic therapy results in a survival … There have been other randomized clinical trials studying …

… In conclusion, first-line treatment with gefitinib conferred prolonged progression-free
survival than treatment with systemic chemotherapy in a molecularly or histologically defined …

… in a randomized, placebo-controlled phase III trial concluding that the addition of concurrent
… progression-free survival in front-line treatment of advanced ovarian cancer compared to …

… , EMBASE, ClinicalTrials.gov ) to identify randomized controlled trials (RCTs) comparing
IV LZP versus IV DZP used as first-line treatment for convulsive SE (generalized or focal). …

… insufficient studies to form well-connected networks. Our findings confirmed the efficacy of
metformin as the first-line treatment for T2DM in consistency with the current clinical guidelines …

… clinical trials in metastatic breast cancer have been published without HRQOL data. Unfortunately,
such studies do not weigh the benefits of treatment … can impair clinical decision making…

… III clinical trial Checkmate-214 showed a survival superiority for the combination of ipilimumab
and nivolumab when compared with the previous standard of care in first-line metastatic/…

… derived from randomized controlled trials. Though our … compared to similar clinical trials,
notably the IMbrave 150 trial (3… , a factor typically excluded from clinical trial eligibility criteria. As …

… Data extracted from eligible randomized controlled trials were entered into a … first-line
regimens and to explore their effectiveness rank order. The ranking probability for each regimen …

… To our knowledge, this is the first randomized trial aimed at comparing paclitaxel therapy
and platinum-based therapy in patients relapsing after 12 months of complete remission. …